"Thromboxane-A Synthase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5.
| Descriptor ID |
D013930
|
| MeSH Number(s) |
D08.811.399.475.900
|
| Concept/Terms |
Thromboxane-A Synthase- Thromboxane-A Synthase
- Synthase, Thromboxane-A
- Thromboxane A2 Synthetase
- A2 Synthetase, Thromboxane
- Synthetase, Thromboxane A2
- Thromboxane Synthetase
- Synthetase, Thromboxane
- Thromboxane A Synthase
- Synthase, Thromboxane A
|
Below are MeSH descriptors whose meaning is more general than "Thromboxane-A Synthase".
Below are MeSH descriptors whose meaning is more specific than "Thromboxane-A Synthase".
This graph shows the total number of publications written about "Thromboxane-A Synthase" by people in this website by year, and whether "Thromboxane-A Synthase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thromboxane-A Synthase" by people in Profiles.
-
Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat. 2011 Nov; 96(1-4):41-4.
-
Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene. 2008 Jan 03; 27(1):55-62.
-
Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res. 2005 Dec 15; 65(24):11581-7.
-
Evaluation of the whole prostaglandin biosynthetic pathway in lung cancer. Clin Cancer Res. 2003 May; 9(5):1577-8.
-
The beneficial effects of a thromboxane receptor antagonist on spinal cord perfusion following experimental cord injury. J Neurol Sci. 1992 Jun; 109(2):162-7.
-
Effects of thromboxane synthetase inhibition on patency and anastomotic hyperplasia of vascular grafts. J Surg Res. 1989 Jun; 46(6):611-5.
-
The rat in sepsis and endotoxic shock. Prog Clin Biol Res. 1989; 299:243-52.
-
Improvement in organ blood flow by inhibition of thromboxane synthetase during experimental endotoxic shock in the rat. J Cardiovasc Pharmacol. 1986 May-Jun; 8(3):514-9.
-
Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology. 1986 Apr; 36(4):466-70.
-
Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med. 1986; 12(3):116-26.